2,0
21. Juni 2022
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Nice office and medical benefits
Kontras
Unwilling to invest yet sets high growth ambition, plenty of talk but no action, weak regional team with no real value add, finance working in silo looking at P&L as a paper or math exercise with no understanding of real work requirements, plenty of turn-over.